Low density lipoproteins and lovastatin modulate the organ-specific transendothelial migration of primary and metastatic human colon adenocarcinoma cell lines in vitro

Clinical and Experimental Metastasis

Volumn 16, Issue 7, 1998, Pages 587-594

  Mehta, Nikhil ^a   Hordines, John ^a   Sykes, Donald ^a   Doerr, Ralph J ^a   Cohen, Stefan A ^a,b  

^a BUFFALO GENERAL HOSPITAL   (United States)

^b VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

Author keywords

Metastasis; Organ specificity; Tumor invasion

Indexed keywords

LOW DENSITY LIPOPROTEIN; MEVINOLIN;

ANTIBODY SPECIFICITY; ARTICLE; CANCER INVASION; CELL ADHESION; CELL INTERACTION; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CHOLESTEROL SYNTHESIS; COLON ADENOCARCINOMA; DRUG EFFECT; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; METASTASIS; MICROVASCULATURE;

ADENOCARCINOMA; ANIMALS; CELL ADHESION; CELL MOVEMENT; COLONIC NEOPLASMS; ENDOTHELIUM, VASCULAR; HUMANS; LIPOPROTEINS, LDL; LIVER NEOPLASMS; LOVASTATIN; MICE; MICE, INBRED BALB C; ORGAN SPECIFICITY; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0032430478     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006548902592     Document Type: Article

References (30)

1. 1. Fidler IJ, 1990, Critical factors in the biology of human cancer metastasis: twenty-eighth Clowes Memorial Award Lecture. Cancer Res, 50, 6130-8.
2. 2. Mehta N, Hordines J, Volpe C, Doerr R and Cohen SA, 1997, Cellular effects of hyper-cholesterolemia in modulation of cancer growth and metastasis: a review of the evidence. Surg. Oncol, 7, 179-86.
3. 3. Cohen SA, Mahl T, Montesanti D, Hassett M and Barbera-Guillem E, 1995, Capacity of nonparenchymal liver cells to control metastasis. In Bouwens L, ed. NK Cells in the Liver. Austin, Landes Co. pp. 71-100.
4. 4. Holland JA, Pritchard KA and Rogers NJ, 1993, Stemerman M.B: Perturbation of cultured endothelial cells by atherogenic levels of low density lipoprotein. Am J Pathol, 132, 474-8.
5. 5. Lafrenie R, Shaughnessy SG and Orr FW, 1992, Cancer cell interactions with injured or activated endothelium. Cancer Mets Rev, 11, 377-88.
6. 6. Alberts AW, Chen J and Kuron G, 1980, Mevinolin: a highly potent competitive inhibitor of HMG-CoA reductase and a cholesterol lowering agent. Proc Natl Acad Sci, 77, 3957-61.
7. 7. Sumi B, Beauchamp RD and Townsend CM, 1992, Inhibition of pancreatic adenocarcinoma cell growth by lovastatin. Gastroenterology, 103, 982-9.
8. 8. Vincent TS, Wulfert E and Merler E, 1991, Inhibition of growth factor signaling pathways by lovastatin. Biochem Biophys, Res Commun, 180, 1284-9.
9. 9. Gebhardi A and Niendorf A, 1995, Effects of prevastatin, a hydroxymethyl glutaryl-CoA reductase inhibitor, on two human tumor cell lines. J Can Res Clin Oncol, 121, 343-9.
10. 10. Barbera-Guillem E, Alonso-Varona A and Vidal-Vanachlocha F, 1989, Selective implantation and growth of liver metastasis in acinar zone one. Cancer Res, 49, 4003-10.
11. 11. Schackert G, Price JE, Bucana CD and Fidler IJ, 1989, Unique patterns of brain metastasis produced by different human carcinomas in athymic nude mice. Int J Cancer, 44, 892-7.
12. 12. Auerbach R et al, 1987, Specificity of adhesion between murine tumor cells and capillary endothelium: an in vitro correlate of preferential metastasis in vivo. Cancer Res, 47, 1492-6.
13. 13. Pauli B et al., 1990, Organ preference of metastasis: the role of endothelial cell adhesion molecules. Cancer Mets Rev, 9, 175-89.
14. 14. McCarthy SA, Kuzu I, Gatter KC and Bicknell R, 1991, Heterogeneity of the endothelial cell and its role in organ preference of tumor metastasis. TIBS, 12, 462-7.
15. 15. Danforth DN and Sgagias MK, 1993, Interleukin-1 alpha and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro. Cancer Res, 53, 1538-45.
16. 16. Reed MJ, Topping L, Coldham NG, Purohit A, Ghilchik MW and James VH, 1993, Control of aromatase activity in breast cancer cells: the role of cytokines and growth factors. J Steroid Biochem Mol Biol, 44, 589-96.
17. 17. Cruse JP, Lewin MR and Clark CJ, 1982, Dietary cholesterol deprivation improves survival and reduces the incidence of metastatic colon cancer in dimethyl-hydrazide treated rats. Gut, 23, 594-9.
18. 18. Kort WJ, Hulsmann WC and Stehman TE, 1989, Modulation of metastatic ability by inhibition of cholesterol synthesis. Clin Exp Metastasis, 7, 517-23.
19. 19. Henriksen T, Evensen SA and Carlander B, 1979, Injury to human endothelial cells in culture induced by low density lipoproteins. Scand J Clin Lab Invest, 39, 361-8.
20. 20. Okada M, Sugita O, Miida T, Matsuto T and Inano K, 1995, Effects of modified low density lipoprotein and hypoxia on the expression of endothelial leukocyte adhesion molecule-1. Presse Medicale, 24, 483-8.
21. 21. Morgan J, Smith JA, Wikins GM and Leake DS, 1993, Oxidation of low density lipoprotein by bovine and porcine aortic endothelial cells and porcine endocardial cells in culture. Atherosclerosis, 102, 209-16.
22. 22. Murakami M, Ushio Y, Mihara Y, Kuratsu J, Horiuchi S and Morino Y, 1990, Cholesterol uptake by human glioma cells via receptor mediated endocytosis of low density lipoprotein. J Neurosurg, 73, 760-7.
23. 23. Chambers AF, MacDonald IC, Schmidt EE, et al., 1995, Steps in tumor metastases: new concepts from intravidal videomicroscopy. Cancer Met Rev, 14, 279-301.
24. 24. Pritchard KA, Grozek L, Smalley DM, et al., 1995, Native low-density lipoprotein increases endothelial nitric oxide synthetase generation of super oxide anion. Circulation Res, 77, 510-8.
25. 25. Vitols S, 1991, Uptake of low density lipoprotein by malignant cells - possible therapeutic applications (Review). Cancer Cells, 3, 488-95.
26. 26. Miller AC and Samid D, 1995, Tumor resistance to oxidative stress: association with ras oncogene expression and reversal by lovastatin, an inhibitor of p21ras isoprenylation. Int J Cancer, 60, 249-54.
27. 27. Khan SG, Saxena R, Bickers DR, Mukhtar H and Agarwal R, 1995, Inhibition of ras p21 membrane localization and modulation of protein kinase C isozyme expression during regression of chemical carcinogen-induced murine skin tumors by lovastatin. Molec Carcino, 12, 205-12.
28. 28. Jones KD, Couldwell WJ, Hinton DR, et al., 1991, Lovastatin induces growth inhibition and apoptosis in malignant human glioma cells. Biochem Biophys Res Commun 205, 1671-81.
29. 29. Miller AC, Kariko K, Myers CE, Clark EP and Samid D, 1993, Increased radioresistance of EJ ras-transformed human osteosarcoma cells and its modulation by lovastatin, an inhibitor of p21 ras isoprenylation. Int J Cancer, 53, 302-7.
30. 30. Jani JP, Specht S, Stemmler N, et al., 1993, Metastasis B16F10 mouse melanoma inhibited by lovastatin, an inhibitor of cholesterol biosynthesis. Invasion and Metastasis, 13, 314-24.